Arcutis Biotherapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
LOCK KENNETH A. officer: Chief Commercial Officer
 Stock Option (Right to Buy) 7,500 $6.52 $48,900
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
 Common Stock 496,000 $25 $12,400,000
Purchase
SILVERSTEIN JONATHAN director, 10 percent owner
 Common Stock 496,000 $25 $12,400,000
Option
WELGUS HOWARD G. director
 Common Stock 2,200 $13.43 $29,548
Option
WELGUS HOWARD G. director
 Stock Option (Right to Buy) 2,200 $13.43 $29,548
Sale
WELGUS HOWARD G. director
 Common Stock 390 $25.18 $9,821
Sale
WATANABE TODD FRANKLIN director, officer: President an..
 Common Stock 3,000 $1.68 $5,043
Option
SMITHER JOHN W officer: Chief Financial Officer
 Common Stock 500 $1.68 $841
Option
SMITHER JOHN W officer: Chief Financial Officer
 Stock Option (Right to Buy) 500 $1.68 $841
Sale
OSBORNE DAVID W officer: Chief Technical Officer
 Common Stock 15,000 $30 $450,000
Sale
SMITHER JOHN W officer: Chief Financial Officer
 Common Stock 1,750 $15.84 $27,720
Option
WATANABE TODD FRANKLIN director, officer: President an..
 Stock Option (Right to Buy) 3,000 $1.68 $5,043
Option
WATANABE TODD FRANKLIN director, officer: President an..
 Common Stock 3,000 $1.68 $5,043
Option
WELGUS HOWARD G. director
 Common Stock 1,222 $0.58 $709
Option
WELGUS HOWARD G. director
 Stock Option (Right to Buy) 1,222 $0.58 $709
Sale
WELGUS HOWARD G. director
 Common Stock 2,200 $1.68 $3,696
Option
WELGUS HOWARD G. director
 Stock Option (Right to Buy) 4,400 $9.25 $40,691
Option
WELGUS HOWARD G. director
 Common Stock 4,400 $9.25 $40,691
Option
WELGUS HOWARD G. director
 Stock Option (Right to Buy) 5,000 $1.68 $8,400
Option
WELGUS HOWARD G. director
 Common Stock 5,000 $1.68 $8,400
Option
WELGUS HOWARD G. director
 Stock Option (Right to Buy) 5,076 $1.68 $8,528
Option
WELGUS HOWARD G. director
 Common Stock 5,076 $1.68 $8,528
Option
WELGUS HOWARD G. director
 Common Stock 6,110 $0.58 $3,544
Option
WELGUS HOWARD G. director
 Stock Option (Right to Buy) 6,110 $0.58 $3,544
Sale
WELGUS HOWARD G. director
 Common Stock 2,733 $1.68 $4,591
Option
WELGUS HOWARD G. director
 Stock Option (Right to Buy) 2,800 $13.66 $38,234
Option
WELGUS HOWARD G. director
 Common Stock 2,800 $13.66 $38,234
Option
SMITHER JOHN W officer: Chief Financial Officer
 Stock Option (Right to Buy) 14,875 $1.68 $25,005
Option
SMITHER JOHN W officer: Chief Financial Officer
 Common Stock 14,875 $1.68 $25,005
Option
WATANABE TODD FRANKLIN director, officer: President an..
 Common Stock 59,481 $1.68 $99,988
Option
WATANABE TODD FRANKLIN director, officer: President an..
 Stock Option (Right to Buy) 59,481 $1.68 $99,988
Option
WELGUS HOWARD G. director
 Stock Option (Right to Buy) 6,110 $0.58 $3,544
Option
WELGUS HOWARD G. director
 Common Stock 6,110 $0.58 $3,544
Purchase
HERON PATRICK J director, 10 percent owner
 Common Stock 500,000 $17 $8,500,000
Purchase
FRAZIER LIFE SCIENCES VIII, L.P. 10 percent owner
 Common Stock 500,000 $17 $8,500,000
Purchase
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC 10 percent owner
 Common Stock 294,117 $17 $4,999,989
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
 Common Stock 558,888 $17 $9,501,096
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
 Common Stock 558,888 $17 $9,501,096
Purchase
SILVERSTEIN JONATHAN director, 10 percent owner
 Common Stock 558,888 $17 $9,501,096
Purchase
SILVERSTEIN JONATHAN director, 10 percent owner
 Common Stock 558,888 $17 $9,501,096

Showing 350 to 390 of 390 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: